Predicting CD27 expression and clinical prognosis in serous ovarian cancer using CT-based radiomics

Chen Zhang,Heng Cui,Yi Li,Xiaohong Chang

DOI: https://doi.org/10.1186/s13048-024-01456-7

2024-06-24

Journal of Ovarian Research

Abstract:This study aimed to develop and evaluate radiomics models to predict CD27 expression and clinical prognosis before surgery in patients with serous ovarian cancer (SOC).

reproductive biology

What problem does this paper attempt to address?

CT-based radiomics predicts CD38 expression and indirectly reflects clinical prognosis in epithelial ovarian cancer

Yuan Yao,Haijin Zhang,Hui Liu,Chendi Teng,Xuan Che,Wei Bian,Wenting Zhang,Zhifeng Wang

DOI: https://doi.org/10.1016/j.heliyon.2024.e32910

IF: 3.776

2024-06-13

Heliyon

Abstract:Background: Cluster of differentiation 38 (CD38) has been found to be highly expressed in various solid tumours, and its expression level may be associated with patient prognosis and survival. This study aimed to evaluate the prognostic value of CD38 expression for patients with epithelial ovarian cancer (EOC) and construct two computed tomography (CT)-based radiomics models for predicting CD38 expression. Methods: A total of 333 cases of EOC were enrolled from The Cancer Genome Atlas (TCGA) database for CD38-related bioinformatics and survival analysis. A total of 56 intersection cases from TCGA and The Cancer Imaging Archive (TCIA) databases were selected for radiomics feature extraction and model construction. Logistic regression (LR) and support vector machine (SVM) models were constructed and internally validated using 5-fold cross-validation to assess the performance of the models for CD38 expression levels. Results: High CD38 expression was an independent protective factor (HR = 0.540) for overall survival (OS) in EOC patients. Five radiomics features based on CT images were selected to build models for the prediction of CD38 expression. In the training and internal validation sets, for the receiver operating characteristic (ROC) curve, the LR model reached an area under the curve (AUC) of 0.739 and 0.732, while the SVM model achieved AUC values of 0.741 and 0.700, respectively. For the precision-recall (PR) curve, the LR and SVM models demonstrated an AUC of 0.760 and 0.721. The calibration curves and decision curve analysis (DCA) provided evidence supporting the fitness and net benefit of the models. Conclusions: High levels of CD38 expression can improve OS in EOC patients. CT-based radiomics models can be a new predictive tool for CD38 expression, offering possibilities for individualised survival assessment for patients with EOC.
Radiomics Signatures Based on Computed Tomography for Noninvasive Prediction of CXCL10 Expression and Prognosis in Ovarian Cancer

Xiaohua Wang,Yuanyuan Xing,Xuan Zhou,Chunhui Wang,Shuyu Han,Sufen Zhao

DOI: https://doi.org/10.1002/cnr2.70030

Abstract:Background: Ovarian cancer (OC) is an aggressive gynecological tumor usually diagnosed with malignant ascites and even observed widespread metastasis or distant spread. Aims: We aimed to develop and identify radiomics models according to computed tomography (CT) for preoperative prediction of CXCL10 expression and prognosis in patients with OC. Methods: Genomic data with CT images and corresponding clinicopathological parameters were extracted from The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA). To analyze the prognosis, we carried out the univariate Cox regression analysis (UCRA), multivariate Cox regression analysis (MCRA), and Kaplan-Meier (KM) analysis. For the data reduction, logistic regression, operator regression, least absolute shrinkage selection, radiomic feature construction, and feature selection were utilized. The predictive performance of the radiomic signatures was assessed using the analyses of the receiver operating characteristic (ROC) curve, decision curve (DCA), and precision-recall (PR) curve. To evaluate the correlation between the radiomic score (Rad-score) and CXCL10 expression, the Wilcoxon rank-sum test was applied. Results: Three radiomics models effectively predicted CXCL10 expression levels (AUC = 0.791, 0.748, and 0.718 for the set of training; AUC = 0.761, 0.746, and 0.701 for the set of validation). A higher Rad-score significantly correlated with upregulated CXCL10 expression. Conclusion: CXCL10 expression can be predicted noninvasively and preoperatively via radiomic signatures based on contrast-enhanced CT images.
Development of Survival Predictors for High-Grade Serous Ovarian Cancer Based on Stable Radiomic Features from Computed Tomography Images

Jiaqi Hu,Zhiwu Wang,Ruocheng Zuo,Chengcai Zheng,Bingjian Lu,Xiaodong Cheng,Weiguo Lu,Chunhui Zhao,Pengyuan Liu,Yan Lu

DOI: https://doi.org/10.1016/j.isci.2022.104628

IF: 5.8

2022-01-01

iScience

Abstract:Less than 35% of advanced patients with high-grade serous ovarian cancer (HGSOC) survive for 5 years after diagnosis. Here, we developed radiomics-based models to predict HGSOC clinical outcomes using preoperative contrast-enhanced computed tomography (CECT) images. 891 radiomics features were extracted between primary, metastatic, or lymphatic lesions from preoperative venous phase CECT images of 217 patients with HGSOC. A heuristic method, Frequency Appearance in Multiple Univariate preScreening (FAMUS), was proposed to identify stable and task-relevant radiomic features. Using FAMUS, we constructed predictive models of overall survival and disease-free survival in patients with HGSOC based on these stable radiomic features. According to their CT images, patients with HGSOC can be accurately stratified into high-risk or low-risk groups for cancer-related death within 2-6 years or for likely recurrence within 1-5 years. These radiomic models provide convincing and reliable non-invasive markers for individualized prognostic evaluation and clinical decision-making for patients with HGSOC.
Multitask prediction models for serous ovarian cancer by preoperative CT image assessments based on radiomics

Le Fu,Wenjing Wang,Lingling Lin,Feng Gao,Jiani Yang,Yunyun Lv,Ruiqiu Ge,Meixuan Wu,Lei Chen,Aie Liu,Enhui Xin,Jianli Yu,Jiejun Cheng,Yu Wang

DOI: https://doi.org/10.3389/fmed.2024.1334062

IF: 3.9

2024-02-06

Frontiers in Medicine

Abstract:Objective High-grade serous ovarian cancer (HGSOC) has the highest mortality rate among female reproductive system tumors. Accurate preoperative assessment is crucial for treatment planning. This study aims to develop multitask prediction models for HGSOC using radiomics analysis based on preoperative CT images. Methods This study enrolled 112 patients diagnosed with HGSOC. Laboratory findings, including serum levels of CA125, HE-4, and NLR, were collected. Radiomic features were extracted from manually delineated ROI on CT images by two radiologists. Classification models were developed using selected optimal feature sets to predict R0 resection, lymph node invasion, and distant metastasis status. Model evaluation was conducted by quantifying receiver operating curves (ROC), calculating the area under the curve (AUC), De Long’s test. Results The radiomics models applied to CT images demonstrated superior performance in the testing set compared to the clinical models. The area under the curve (AUC) values for the combined model in predicting R0 resection were 0.913 and 0.881 in the training and testing datasets, respectively. De Long’s test indicated significant differences between the combined and clinical models in the testing set ( p = 0.003). For predicting lymph node invasion, the AUCs of the combined model were 0.868 and 0.800 in the training and testing datasets, respectively. The results also revealed significant differences between the combined and clinical models in the testing set ( p = 0.002). The combined model for predicting distant metastasis achieved AUCs of 0.872 and 0.796 in the training and test datasets, respectively. The combined model displayed excellent agreement between observed and predicted results in predicting R0 resection, while the radiomics model demonstrated better calibration than both the clinical model and combined model in predicting lymph node invasion and distant metastasis. The decision curve analysis (DCA) for predicting R0 resection favored the combined model over both the clinical and radiomics models, whereas for predicting lymph node invasion and distant metastasis, DCA favored the radiomics model over both the clinical model and combined model. Conclusion The identified radiomics signature holds potential value in preoperatively evaluating the R0, lymph node invasion and distant metastasis in patients with HGSC. The radiomics nomogram demonstrated the incremental value of clinical predictors for surgical outcome and metastasis estimation.

medicine, general & internal
Developing survival predictors for high-grade serous ovarian cancer based on radiomic features from CT images with stability against sample variation

Jiaqi Hu,Zhiwu Wang,Ruocheng Zuo,Chengcai Zheng,Bingjian Lu,Xiaodong Cheng,Weiguo Lu,Chunhui Zhao,Pengyuan Liu,Yan Lu

DOI: https://doi.org/10.1016/j.isci.2022.104628

IF: 5.8

2022-01-01

iScience

Abstract:<h2>Summary</h2> Less than 35% of advanced patients with high-grade serous ovarian cancer (HGSOC) survive for 5 years after diagnosis. Here, we developed radiomics-based models to predict HGSOC clinical outcomes using preoperative contrast-enhanced computed tomography (CECT) images. 891 radiomics features were extracted between primary, metastatic, or lymphatic lesions from preoperative venous phase CECT images of 217 patients with HGSOC. A heuristic method, Frequency Appearance in <b>M</b>ultiple <b>U</b>nivariate pre<b>S</b>creening (FAMUS), was proposed to identify stable and task-relevant radiomic features. Using FAMUS, we constructed predictive models of overall survival and disease-free survival in patients with HGSOC based on these stable radiomic features. According to their CT images, patients with HGSOC can be accurately stratified into high-risk or low-risk groups for cancer-related death within 2-6 years or for likely recurrence within 1-5 years. These radiomic models provide convincing and reliable non-invasive markers for individualized prognostic evaluation and clinical decision-making for patients with HGSOC.
CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer

Sheng Wan,Tianfan Zhou,Ronghua Che,Ying Li,Jing Peng,Yuelin Wu,Shengyi Gu,Jiejun Cheng,Xiaolin Hua

DOI: https://doi.org/10.1186/s13048-022-01089-8

2023-01-04

Journal of Ovarian Research

Abstract:We aimed to evaluate the prognostic value of C-C motif chemokine receptor type 5 (CCR5) expression level for patients with ovarian cancer and to establish a radiomics model that can predict CCR5 expression level using The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA) database.

reproductive biology
A Computed Tomography-Based Radiomic Prognostic Marker of Advanced High-Grade Serous Ovarian Cancer Recurrence: A Multicenter Study

Wei Wei,Zhenyu Liu,Yu Rong,Bin Zhou,Yan Bai,Wei Wei,Shuo Wang,Meiyun Wang,Yingkun Guo,Jie Tian

DOI: https://doi.org/10.3389/fonc.2019.00255

IF: 4.7

2019-04-09

Frontiers in Oncology

Abstract:Objectives: We used radiomic analysis to establish a radiomic signature based on preoperative contrast enhanced computed tomography (CT) and explore its effectiveness as a novel recurrence risk prognostic marker for advanced high-grade serous ovarian cancer (HGSOC).Methods: This study had a retrospective multicenter (two hospitals in China) design and a radiomic analysis was performed using contrast enhanced CT in advanced HGSOC (FIGO stage III or IV) patients. We used a minimum 18-month follow-up period for all patients (median 38.8 months, range 18.8–81.8 months). All patients were divided into three cohorts according to the timing of their surgery and hospital stay: training cohort (TC) and internal validation cohort (IVC) were from one hospital, and independent external validation cohort (IEVC) was from another hospital. A total of 620 3-D radiomic features were extracted and a Lasso-Cox regression was used for feature dimension reduction and determination of radiomic signature. Finally, we combined the radiomic signature with seven common clinical variables to develop a novel nomogram using a multivariable Cox proportional hazards model.Results: A final 142 advanced HGSOC patients were enrolled. Patients were successfully divided into two groups with statistically significant differences based on radiomic signature, consisting of four radiomic features (log-rank test P = 0.001, <0.001, <0.001 for TC, IVC, and IEVC, respectively). The discrimination accuracies of radiomic signature for predicting recurrence risk within 18 months were 82.4% (95% CI, 77.8–87.0%), 77.3% (95% CI, 74.4–80.2%), and 79.7% (95% CI, 73.8–85.6%) for TC, IVC, and IEVC, respectively. Further, the discrimination accuracies of radiomic signature for predicting recurrence risk within 3 years were 83.4% (95% CI, 77.3–89.6%), 82.0% (95% CI, 78.9–85.1%), and 70.0% (95% CI, 63.6–76.4%) for TC, IVC, and IEVC, respectively. Finally, the accuracy of radiomic nomogram for predicting 18-month and 3-year recurrence risks were 84.1% (95% CI, 80.5–87.7%) and 88.9% (95% CI, 85.8–92.5%), respectively.Conclusions: Radiomic signature and radiomic nomogram may be low-cost, non-invasive means for successfully predicting risk for postoperative advanced HGSOC recurrence before or during the perioperative period. Radiomic signature is a potential prognostic marker that may allow for individualized evaluation of patients with advanced HGSOC.

oncology
Prediction of ovarian cancer prognosis using statistical radiomic features of ultrasound images

Ruochen Zuo,Xiuru Li,Jiaqi Hu,Wenqian Wang,Bingjian Lu,Honghe Zhang,Xiaodong Cheng,Weiguo Lu,Jiale Qin,Pengyuan Liu,Yan Lu

DOI: https://doi.org/10.1088/1361-6560/ad4a02

IF: 3.5

2024-05-13

Physics in Medicine and Biology

Abstract:Ovarian cancer is the deadliest gynecologic malignancy worldwide. Ultrasound is the most useful non-invasive test for preoperative diagnosis of ovarian cancer. In this study, by leveraging multiple ultrasound images from the same patient to generate personalized, informative statistical radiomic features, we aimed to develop improved ultrasound image-based prognostic models for ovarian cancer. A total of 2,057 ultrasound images from 514 ovarian cancer patients, including 355 patients with epithelial ovarian cancer, from two hospitals in China were collected for this study. The models were constructed using our recently developed Frequency Appearance in Multiple Univariate pre-Screening (FAMUS) feature selection algorithm and Cox proportional hazards model. The models showed high predictive performance for overall survival (OS) and recurrence-free survival (RFS) in both epithelial and nonepithelial ovarian cancer, with concordance indices (C-index) ranging from 0.773 to 0.794. Radiomic scores predicted 2-year OS and RFS risk groups with significant survival differences (log-rank test, P<1.0e-4 for both validation cohorts). OS and RFS hazard ratios between low- and high-risk groups were 15.994 and 30.692 (internal cohort) and 19.339 and 19.760 (external cohort), respectively. The improved performance of these newly developed prognostic models was mainly attributed to the use of multiple preoperative ultrasound images from the same patient to generate statistical radiomic features, rather than simply using the largest tumor ROI among them. The models also revealed that the roundness of tumor lesion shape was positively correlated with prognosis for ovarian cancer. In summary, the newly developed prognostic models based on statistical radiomic features from ultrasound images were highly predictive of the risk of cancer-related death and possible recurrence not only for patients with epithelial ovarian cancer but also for those with nonepithelial ovarian cancer. They thereby provide reliable, non-invasive markers for individualized prognosis evaluation and clinical decision-making for patients with ovarian cancer.

engineering, biomedical,radiology, nuclear medicine & medical imaging
Seeing beyond the tumor: computed tomography image-based radiomic analysis helps identify ovarian clear cell carcinoma subtype in epithelial ovarian cancer

Jing Ren,Li Mao,Jia Zhao,Xiu-Li Li,Chen Wang,Xin-Yu Liu,Zheng-Yu Jin,Yong-Lan He,Yuan Li,Hua-Dan Xue

DOI: https://doi.org/10.1007/s11547-023-01666-x

Abstract:Objective: To develop and validate a model that can preoperatively identify the ovarian clear cell carcinoma (OCCC) subtype in epithelial ovarian cancer (EOC) using CT imaging radiomics and clinical data. Material and methods: We retrospectively analyzed data from 282 patients with EOC (training set = 225, testing set = 57) who underwent pre-surgery CT examinations. Patients were categorized into OCCC or other EOC subtypes based on postoperative pathology. Seven clinical characteristics (age, cancer antigen [CA]-125, CA-199, endometriosis, venous thromboembolism, hypercalcemia, stage) were collected. Primary tumors were manually delineated on portal venous-phase images, and 1218 radiomic features were extracted. The F-test-based feature selection method and logistic regression algorithm were used to build the radiomic signature, clinical model, and integrated model. To explore the effects of integrated model-assisted diagnosis, five radiologists independently interpreted images in the testing set and reevaluated cases two weeks later with knowledge of the integrated model's output. The diagnostic performances of the predictive models, radiologists, and radiologists aided by the integrated model were evaluated. Results: The integrated model containing the radiomic signature (constructed by four wavelet radiomic features) and three clinical characteristics (CA-125, endometriosis, and hypercalcinemia), showed better diagnostic performance (AUC = 0.863 [0.762-0.964]) than the clinical model (AUC = 0.792 [0.630-0.953], p = 0.295) and the radiomic signature alone (AUC = 0.781 [0.636-0.926], p = 0.185). The diagnostic sensitivities of the radiologists were significantly improved when using the integrated model (p = 0.023-0.041), while the specificities and accuracies were maintained (p = 0.074-1.000). Conclusion: Our integrated model shows great potential to facilitate the early identification of the OCCC subtype in EOC, which may enhance subtype-specific therapy and clinical management.
CT-based radiomic analysis for categorization of ovarian sex cord-stromal tumors and epithelial ovarian cancers

Yu Liu,Xin Zheng,Dongdong Fan,Zhou Shen,Zhifa Wu,Shuang Li

DOI: https://doi.org/10.1007/s00261-024-04437-y

IF: 2.4

2024-06-21

Abdominal Radiology

Abstract:To evaluate the diagnostic potential of radiomic analyses based on machine learning that rely on contrast-enhanced computerized tomography (CT) for categorizing ovarian sex cord-stromal tumors (SCSTs) and epithelial ovarian cancers (EOCs).

radiology, nuclear medicine & medical imaging
The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer

Hui-zhu Chen,Xin-rong Wang,Fu-min Zhao,Xi-jian Chen,Xue-sheng Li,Gang Ning,Ying-kun Guo

DOI: https://doi.org/10.3389/fonc.2021.711648

IF: 4.7

2021-08-31

Frontiers in Oncology

Abstract:Purpose To develop and validate a radiomics model for predicting preoperative lymph node (LN) metastasis in high-grade serous ovarian cancer (HGSOC). Materials and Methods From May 2008 to January 2018, a total of 256 eligible HGSOC patients who underwent tumor resection and LN dissection were divided into a training cohort (n=179) and a test cohort (n=77) in a 7:3 ratio. A Radiomics Model was developed based on a training cohort of 179 patients. A radiomics signature (defined as the Radscore) was selected by using the random forest method. Logistics regression was used as the classifier for modeling. An Integrated Model that incorporated the Radscore and CT_reported LN status (CT_LN_report) was developed and presented as a radiomics nomogram. Its performance was determined by the area under the curve (AUC), calibration, and decision curve. The radiomics nomogram was internally tested in an independent test cohort (n=77) and a CT-LN-report negative subgroup (n=179) using the formula derived from the training cohort. Results The AUC value of the CT_LN_report was 0.688 (95% CI: 0.626, 0.759) in the training cohort and 0.717 (95% CI: 0.630, 0.804) in the test cohort. The Radiomics Model yielded an AUC of 0.767 (95% CI: 0.696, 0.837) in the training cohort and 0.753 (95% CI: 0.640, 0.866) in the test. The radiomics nomogram demonstrated favorable calibration and discrimination in the training cohort (AUC=0.821), test cohort (AUC=0.843), and CT-LN-report negative subgroup (AUC=0.82), outperforming the Radiomics Model and CT_LN_report alone. Conclusions The radiomics nomogram derived from portal phase CT images performed well in predicting LN metastasis in HGSOC and could be recommended as a new, convenient, and non-invasive method to aid in clinical decision-making.

oncology
Radiomics nomogram based on CT radiomics features and clinical factors for prediction of Ki-67 expression and prognosis in clear cell renal cell carcinoma: a two-center study

Ben Li,Jie Zhu,Yanmei Wang,Yuchao Xu,Zhaisong Gao,Hailei Shi,Pei Nie,Ju Zhang,Yuan Zhuang,Zhenguang Wang,Guangjie Yang

DOI: https://doi.org/10.1186/s40644-024-00744-1

IF: 5.605

2024-08-06

Cancer Imaging

Abstract:Objectives: To develop and validate a radiomics nomogram combining radiomics features and clinical factors for preoperative evaluation of Ki-67 expression status and prognostic prediction in clear cell renal cell carcinoma (ccRCC). Methods: Two medical centers of 185 ccRCC patients were included, and each of them formed a training group (n = 130) and a validation group (n = 55). The independent predictor of Ki-67 expression status was identified by univariate and multivariate regression, and radiomics features were extracted from the preoperative CT images. The maximum relevance minimum redundancy (mRMR) and the least absolute shrinkage and selection operator algorithm (LASSO) were used to identify the radiomics features that were most relevant for high Ki-67 expression. Subsequently, clinical model, radiomics signature (RS), and radiomics nomogram were established. The performance for prediction of Ki-67 expression status was validated using area under curve (AUC), calibration curve, Delong test, decision curve analysis (DCA). Prognostic prediction was assessed by survival curve and concordance index (C-index). Results: Tumour size was the only independent predictor of Ki-67 expression status. Five radiomics features were finally identified to construct the RS (AUC: training group, 0.821; validation group, 0.799). The radiomics nomogram achieved a higher AUC (training group, 0.841; validation group, 0.814) and clinical net benefit. Besides, the radiomics nomogram provided a highest C-index (training group, 0.841; validation group, 0.820) in predicting prognosis for ccRCC patients. Conclusions: The radiomics nomogram can accurately predict the Ki-67 expression status and exhibit a great capacity for prognostic prediction in patients with ccRCC and may provide value for tailoring personalized treatment strategies and facilitating comprehensive clinical monitoring for ccRCC patients.
Intratumoral and peritumoral CT radiomics in predicting prognosis in patients with chondrosarcoma: a multicenter study

Qiyuan Li,Ning Wang,Yanmei Wang,Xiaoli Li,Qiushi Su,Jing Zhang,Xia Zhao,Zhengjun Dai,Yao Wang,Li Sun,Xuxiao Xing,Guangjie Yang,Chuanping Gao,Pei Nie

DOI: https://doi.org/10.1186/s13244-023-01582-8

IF: 5.0363

2024-01-18

Insights into Imaging

Abstract:To evaluate the efficacy of the CT-based intratumoral, peritumoral, and combined radiomics signatures in predicting progression-free survival (PFS) of patients with chondrosarcoma (CS).

radiology, nuclear medicine & medical imaging
Radiomic features based on pyradiomics predict CD276 expression associated with breast cancer prognosis

Yong Li,Chun-Mei Chen,Wei-Wen Li,Ming-Tao Shao,Yan Dong,Qun-Chen Zhang

DOI: https://doi.org/10.1016/j.heliyon.2024.e37345

IF: 3.776

2024-09-03

Heliyon

Abstract:Background: CD276 is a promising immune checkpoint molecule with significant therapeutic potential. Several clinical trials are currently investigating CD276-targeted therapies. Purpose: This study aims to assess the prognostic significance of CD276 expression levels and to predict its expression using a radiomic approach in breast cancer (BC). Methods: A cohort of 840 patients diagnosed with BC from The Cancer Genome Atlas was included in this study. The Cancer Imaging Archive provided 98 magnetic resonance imaging (MRI) scans, which were randomly allocated to training and validation datasets in a 7:3 ratio. The association between CD276 expression and patient survival was assessed using Cox regression analysis. Feature selection was performed using the maximum relevance minimum redundancy algorithm and recursive feature elimination. Subsequently, support vector machine (SVM) and logistic regression (LR) models were constructed to predict CD276 expression. Results: The expression of CD276 was found to be elevated in BC. It was an independent risk factor for overall survival (hazard ratio = 1.579, 95 % CI: 1.054-2.366). There were eight radiomic features selected in total. In both the training and validation subsets, the SVM and LR models demonstrated favorable predictive abilities with AUC values of 0.744 and 0.740 for the SVM model and 0.742 and 0.735 for the LR model. These results indicate that the radiomic models efficiently differentiate the CD276 expression status. Conclusions: CD276 expression levels can have an impact on cancer prognosis. The MRI-based radiomic signature described in this study can discriminate the CD276 expression status.
Exploring a multiparameter MRI–based radiomics approach to predict tumor proliferation status of serous ovarian carcinoma

Li Liu,Ling Zhao,Yang Jing,Dan Li,Hua Linghu,Haiyan Wang,Linyi Zhou,Yuan Fang,Yongmei Li

DOI: https://doi.org/10.1186/s13244-024-01634-7

IF: 5.0363

2024-03-20

Insights into Imaging

Abstract:To develop a multiparameter magnetic resonance imaging (MRI)-based radiomics approach that can accurately predict the tumor cell proliferation status of serous ovarian carcinoma (SOC).

radiology, nuclear medicine & medical imaging
Contrast-enhanced CT radiomics for preoperative prediction of stage in epithelial ovarian cancer: a multicenter study

Yinping Leng,Ao Kan,Xiwen Wang,Xiaofen Li,Xuan Xiao,Yu Wang,Lan Liu,Lianggeng Gong

DOI: https://doi.org/10.1186/s12885-024-12037-8

IF: 4.638

2024-03-07

BMC Cancer

Abstract:Preoperative prediction of International Federation of Gynecology and Obstetrics (FIGO) stage in patients with epithelial ovarian cancer (EOC) is crucial for determining appropriate treatment strategy. This study aimed to explore the value of contrast-enhanced CT (CECT) radiomics in predicting preoperative FIGO staging of EOC, and to validate the stability of the model through an independent external dataset.

oncology
Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis

Zhe Zhang,Zhiyao Wei,Luyang Zhao,Chenglei Gu,Yuanguang Meng

DOI: https://doi.org/10.1080/01443615.2023.2171778

2023-02-23

Journal of Obstetrics and Gynaecology

Abstract:Ovarian cancer (OC) is characterised by heterogeneity that complicates the prediction of patient survival and treatment outcomes. Here, we conducted analyses to predict the prognosis of patients from the Genomic Data Commons database and validated the predictions by fivefold cross-validation and by using an independent dataset in the International Cancer Genome Consortium database. We analysed the somatic DNA mutation, mRNA expression, DNA methylation, and microRNA expression data of 1203 samples from 599 serous ovarian cancer (SOC) patients. We found that principal component transformation (PCT) improved the predictive performance of the survival and therapeutic models. Deep learning algorithms also showed better predictive power than the decision tree (DT) and random forest (RF). Furthermore, we identified a series of molecular features and pathways that are associated with patient survival and treatment outcomes. Our study provides perspective on building reliable prognostic and therapeutic strategies and further illuminates the molecular mechanisms of SOC. What is already known on this subject? Recent studies have focussed on predicting cancer outcomes based on omics data. But the limitation is the performance of single-platform genomic analyses or the small numbers of genomic analyses. What do the results of this study add? We analysed multi-omics data, found that principal component transformation (PCT) significantly improved the predictive performance of the survival and therapeutic models. Deep learning algorithms also showed better predictive power than did decision tree (DT) and random forest (RF). Furthermore, we identified a series of molecular features and pathways that are associated with patient survival and treatment outcomes. What are the implications of these findings for clinical practice and/or further research? Our study provides perspective on how to build reliable prognostic and therapeutic strategies and further illuminates the molecular mechanisms of SOC for future studies.

obstetrics & gynecology
Intratumoral and Peritumoral Radiomics for Predicting the Prognosis of High-grade Serous Ovarian Cancer Patients Receiving Platinum-Based Chemotherapy

Xiaoyu Huang,Yong Huang,Kexin Liu,Fenglin Zhang,Zhou Zhu,Kai Xu,Ping Li

DOI: https://doi.org/10.1016/j.acra.2024.09.001

2024-09-16

Abstract:Rationale and objectives: This study aimed to develop a deep learning (DL) prognostic model to evaluate the significance of intra- and peritumoral radiomics in predicting outcomes for high-grade serous ovarian cancer (HGSOC) patients receiving platinum-based chemotherapy. Materials and methods: A DL model was trained and validated on retrospectively collected unenhanced computed tomography (CT) scans from 474 patients at two institutions, which were divided into a training set (N = 362), an internal test set (N = 86), and an external test set (N = 26). The model incorporated tumor segmentation and peritumoral region analysis, using various input configurations: original tumor regions of interest (ROIs), ROI subregions, and ROIs expanded by 1 and 3 pixels. Model performance was assessed via hazard ratios (HRs) and receiver operating characteristic (ROC) curves. Patients were stratified into high- and low-risk groups on the basis of the training set's optimal cutoff value. Results: Among the input configurations, the model using an ROI with a 1-pixel peritumoral expansion achieved the highest predictive accuracy. The DL model exhibited robust performance for predicting progression-free survival, with HRs of 3.41 (95% CI: 2.85, 4.08; P < 0.001) in training set, 1.14 (95% CI: 1.03, 1.26; P = 0.012) in internal test set, and 1.32 (95% CI: 1.07, 1.63; P = 0.011) in external test set. KM survival analysis revealed significant differences between the high-risk and low-risk groups (P < 0.05). Conclusion: The DL model effectively predicts survival outcomes in HGSOC patients receiving platinum-based chemotherapy, offering valuable insights for prognostic assessment and personalized treatment planning.
Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram

Jia Li,Hao Zhou,Xiaofei Lu,Yiren Wang,Haowen Pang,Daniel Cesar,Aiai Liu,Ping Zhou

DOI: https://doi.org/10.1186/s12880-023-01111-5

IF: 2.7949

2023-10-12

BMC Medical Imaging

Abstract:Cervical cancer patients receiving radiotherapy and chemotherapy require accurate survival prediction methods. The objective of this study was to develop a prognostic analysis model based on a radiomics score to predict overall survival (OS) in cervical cancer patients.

radiology, nuclear medicine & medical imaging
Prediction of CD3 T Cells and CD8 T Cells Expression Levels in Non-Small Cell Lung Cancer Based on Radiomic Features of CT Images

Lujiao Chen,Lulin Chen,Hongxia Ni,Liyijing Shen,Jianguo Wei,Yang Xia,Jianfeng Yang,Minxia Yang,Zhenhua Zhao

DOI: https://doi.org/10.3389/fonc.2023.1104316

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:BackgroundIn this work, radiomics characteristics based on CT scans were used to build a model for preoperative evaluation of CD3 and CD8 T cells expression levels in patients with non-small cell lung cancer (NSCLC).MethodsTwo radiomics models for evaluating tumor-infiltrating CD3 and CD8 T cells were created and validated using computed tomography (CT) images and pathology information from NSCLC patients. From January 2020 to December 2021, 105 NSCLC patients with surgical and histological confirmation underwent this retrospective analysis. Immunohistochemistry (IHC) was used to determine CD3 and CD8 T cells expression, and all patients were classified into groups with high and low CD3 T cells expression and high and low CD8 T cells expression. The CT area of interest had 1316 radiomic characteristics that were retrieved. The minimal absolute shrinkage and selection operator (Lasso) technique was used to choose components from the IHC data, and two radiomics models based on CD3 and CD8 T cells abundance were created. Receiver operating characteristic (ROC), calibration curve, and decision curve analyses were used to examine the models’ ability to discriminate and their clinical relevance (DCA).ResultsA CD3 T cells radiomics model with 10 radiological characteristics and a CD8 T cells radiomics model with 6 radiological features that we created both demonstrated strong discrimination in the training and validation cohorts. The CD3 radiomics model has an area under the curve (AUC) of 0.943 (95% CI 0.886-1), sensitivities, specificities, and accuracy of 96%, 89%, and 93%, respectively, in the validation cohort. The AUC of the CD8 radiomics model was 0.837 (95% CI 0.745-0.930) in the validation cohort, with sensitivity, specificity, and accuracy values of 70%, 93%, and 80%, respectively. Patients with high levels of CD3 and CD8 expression had better radiographic results than patients with low levels of expression in both cohorts (p<0.05). Both radiomic models were therapeutically useful, as demonstrated by DCA.ConclusionsWhen making judgments on therapeutic immunotherapy, CT-based radiomic models can be utilized as a non-invasive way to evaluate the expression of tumor-infiltrating CD3 and CD8 T cells in NSCLC patients.

Predicting CD27 expression and clinical prognosis in serous ovarian cancer using CT-based radiomics

CT-based radiomics predicts CD38 expression and indirectly reflects clinical prognosis in epithelial ovarian cancer

Radiomics Signatures Based on Computed Tomography for Noninvasive Prediction of CXCL10 Expression and Prognosis in Ovarian Cancer

Development of Survival Predictors for High-Grade Serous Ovarian Cancer Based on Stable Radiomic Features from Computed Tomography Images

Multitask prediction models for serous ovarian cancer by preoperative CT image assessments based on radiomics

Developing survival predictors for high-grade serous ovarian cancer based on radiomic features from CT images with stability against sample variation

CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer

A Computed Tomography-Based Radiomic Prognostic Marker of Advanced High-Grade Serous Ovarian Cancer Recurrence: A Multicenter Study

Prediction of ovarian cancer prognosis using statistical radiomic features of ultrasound images

Seeing beyond the tumor: computed tomography image-based radiomic analysis helps identify ovarian clear cell carcinoma subtype in epithelial ovarian cancer

CT-based radiomic analysis for categorization of ovarian sex cord-stromal tumors and epithelial ovarian cancers

The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer

Radiomics nomogram based on CT radiomics features and clinical factors for prediction of Ki-67 expression and prognosis in clear cell renal cell carcinoma: a two-center study

Intratumoral and peritumoral CT radiomics in predicting prognosis in patients with chondrosarcoma: a multicenter study

Radiomic features based on pyradiomics predict CD276 expression associated with breast cancer prognosis

Exploring a multiparameter MRI–based radiomics approach to predict tumor proliferation status of serous ovarian carcinoma

Contrast-enhanced CT radiomics for preoperative prediction of stage in epithelial ovarian cancer: a multicenter study

Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis

Intratumoral and Peritumoral Radiomics for Predicting the Prognosis of High-grade Serous Ovarian Cancer Patients Receiving Platinum-Based Chemotherapy

Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram

Prediction of CD3 T Cells and CD8 T Cells Expression Levels in Non-Small Cell Lung Cancer Based on Radiomic Features of CT Images